Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Crit Rev Biochem Mol Biol ; 49(1): 1-15, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24099156

RESUMEN

The cellular response to oxygen deprivation is governed largely by a family of transcription factors known as Hypoxia Inducible Factors (HIFs). This review focuses on the molecular mechanisms by which HIFs regulate the transcriptional apparatus to enable the cellular and organismal response to hypoxia. We discuss here how the various HIF polypeptides, their posttranslational modifications, binding partners and transcriptional cofactors affect RNA polymerase II activity to drive context-dependent transcriptional programs during hypoxia.


Asunto(s)
Factor 1 Inducible por Hipoxia/metabolismo , Hipoxia/metabolismo , Activación Transcripcional , Animales , Humanos , Hipoxia/genética , Factor 1 Inducible por Hipoxia/química , Procesamiento Proteico-Postraduccional , ARN Polimerasa II/metabolismo
2.
Cell Rep ; 16(1): 37-47, 2016 06 28.
Artículo en Inglés | MEDLINE | ID: mdl-27320910

RESUMEN

Hypoxia-inducible factors (HIFs) are critical regulators of the cellular response to hypoxia. Despite their established roles in normal physiology and numerous pathologies, the molecular mechanisms by which they control gene expression remain poorly understood. We report here a conserved role for the TIP60 complex as a HIF1 transcriptional cofactor in Drosophila and human cells. TIP60 (KAT5) is required for HIF1-dependent gene expression in fly cells and embryos and colorectal cancer cells. HIF1A interacts with and recruits TIP60 to chromatin. TIP60 is dispensable for HIF1A association with its target genes but is required for HIF1A-dependent chromatin modification and RNA polymerase II activation in hypoxia. In human cells, global analysis of HIF1A-dependent gene activity reveals that most HIF1A targets require either TIP60, the CDK8-Mediator complex, or both as coactivators for full expression in hypoxia. Thus, HIF1A employs functionally diverse cofactors to regulate different subsets of genes within its transcriptional program.


Asunto(s)
Secuencia Conservada , Proteínas de Unión al ADN/metabolismo , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/metabolismo , Histona Acetiltransferasas/metabolismo , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Lisina Acetiltransferasa 5/metabolismo , Acetilación , Animales , Cromatina/metabolismo , Quinasa 8 Dependiente de Ciclina/metabolismo , Drosophila melanogaster/genética , Células HCT116 , Células HEK293 , Histonas/metabolismo , Humanos , Unión Proteica , Subunidades de Proteína/metabolismo , ARN Polimerasa II/metabolismo , Transcripción Genética , Activación Transcripcional
3.
Elife ; 3: e02200, 2014 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-24867637

RESUMEN

The p53 transcription factor is a potent suppressor of tumor growth. We report here an analysis of its direct transcriptional program using Global Run-On sequencing (GRO-seq). Shortly after MDM2 inhibition by Nutlin-3, low levels of p53 rapidly activate ∼200 genes, most of them not previously established as direct targets. This immediate response involves all canonical p53 effector pathways, including apoptosis. Comparative global analysis of RNA synthesis vs steady state levels revealed that microarray profiling fails to identify low abundance transcripts directly activated by p53. Interestingly, p53 represses a subset of its activation targets before MDM2 inhibition. GRO-seq uncovered a plethora of gene-specific regulatory features affecting key survival and apoptotic genes within the p53 network. p53 regulates hundreds of enhancer-derived RNAs. Strikingly, direct p53 targets harbor pre-activated enhancers highly transcribed in p53 null cells. Altogether, these results enable the study of many uncharacterized p53 target genes and unexpected regulatory mechanisms.DOI: http://dx.doi.org/10.7554/eLife.02200.001.


Asunto(s)
Transcripción Genética/fisiología , Proteína p53 Supresora de Tumor/fisiología , Apoptosis/genética , Sitios de Unión , Línea Celular , Humanos , Proteínas Proto-Oncogénicas c-mdm2/antagonistas & inhibidores , ARN/metabolismo , Proteína p53 Supresora de Tumor/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA